Form 4: Trulieve CEO Sells Shares Under 10b5-1 Plan

Sentiment:

Statement of Changes in Beneficial Ownership


Trulieve Cannabis Corp. CEO Kim Rivers has sold a significant number of subordinate voting shares as part of a pre-arranged trading plan.

Summary

  • Kim Rivers, CEO and Chairman of Trulieve Cannabis Corp., has reported the sale of subordinate voting shares through a Rule 10b5-1 trading plan.
  • Transactions occurred on June 23, 24, and 25, 2026.
  • A total of 1,080,000 subordinate voting shares were sold across these dates.
  • The sales generated proceeds ranging from $8.00 to $8.75 per share, with weighted average prices reported for each day.
  • Following these transactions, Rivers' direct beneficial ownership of subordinate voting shares decreased.
  • Rivers also holds Multiple Voting Shares, convertible into subordinate voting shares on a 1-for-100 basis, some of which are held indirectly through Traunch IV LLC.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the significant volume of shares sold by the CEO, despite the sales being conducted under a Rule 10b5-1 plan.

Positives

  • The sales were conducted under a Rule 10b5-1 plan, indicating a pre-determined strategy for stock sales that can provide an affirmative defense against insider trading allegations.
  • The plan was adopted on March 16, 2026, suggesting a structured approach to managing personal holdings.
  • Rivers continues to hold a substantial number of subordinate voting shares and multiple voting shares, indicating continued significant investment in the company.

Negatives

  • A significant number of shares (1,080,000) were sold by the CEO, which could be perceived negatively by the market.
  • The sales represent a reduction in the CEO's direct beneficial ownership of subordinate voting shares.

Risks

  • The sales, even if executed under a 10b5-1 plan, could lead to negative market perception and potentially impact the stock price.
  • Future sales are planned, with a second tranche of shares eligible for sale after September 15, 2026, which could continue to put downward pressure on the stock.

Future Outlook

The reporting person has indicated that a second tranche of shares from the Rule 10b5-1 plan will be eligible for sale after September 15, 2026. This suggests potential for further stock sales in the future.

Management Comments

  • The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, is a common event for executives in the cannabis industry, which often faces capital constraints and regulatory uncertainties. Such sales can sometimes be interpreted by the market as a lack of confidence, though the use of a pre-arranged plan mitigates direct insider trading concerns.

Stakeholder Impact

  • Shareholders may view the CEO's stock sales with concern, potentially leading to short-term negative pressure on the stock price.
  • The continued indirect ownership through Traunch IV LLC suggests ongoing strategic financial arrangements.

Next Steps

  • Further sales of subordinate voting shares may occur after September 15, 2026, as per the Rule 10b5-1 plan.
  • The reporting person will provide detailed pricing information upon request.

Key Dates

DateDescription
03/16/2026Date the Rule 10b5-1 trading plan was adopted.
06/17/2026Date a Form 144 was filed covering the first tranche of subordinate voting shares.
06/23/2026Date of the earliest reported transaction in this filing.
06/23/2026Transaction date for the sale of 380,000 subordinate voting shares.
06/24/2026Transaction date for the sale of 400,000 subordinate voting shares.
06/25/2026Transaction date for the sale of 300,000 subordinate voting shares.
09/15/2026Date after which the second tranche of shares from the Rule 10b5-1 plan will be eligible for sale.

Recommendation

hold

While the sale of a significant number of shares by the CEO could be a concern, the transactions were executed under a pre-arranged Rule 10b5-1 plan, which is a standard and compliant method for executives to diversify their holdings. The CEO retains substantial indirect and direct ownership, indicating continued commitment. Therefore, a 'hold' recommendation is appropriate, pending further operational and financial developments from Trulieve Cannabis Corp.

Keywords

Trulieve Cannabis Corp., Kim Rivers, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Beneficial Ownership, Subordinate Voting Shares, Multiple Voting Shares, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.